{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-10-23&answeringDeptSortName=Health+and+Social+Care", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2019-10-23&answeringDeptSortName=Health+and+Social+Care", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-10-23&answeringDeptSortName=Health+and+Social+Care&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2019-10-23&answeringDeptSortName=Health+and+Social+Care", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-10-23&answeringDeptSortName=Health+and+Social+Care", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-10-23&answeringDeptSortName=Health+and+Social+Care", "items" : [{"_about" : "http://data.parliament.uk/resources/1150658", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150658/answer", "answerText" : {"_value" : "
A cervical smear may not be the most appropriate test for patients presenting with symptoms. The United Kingdom National Screening Committee (UK NSC) encourages all women who have concerns about their health or who present with symptoms to contact their general practitioner (GP), who will then decide on the most appropriate next steps and diagnostic tests.<\/p>
There have been no discussions with members of the UK NSC in amending National Health Service guidelines to allow cervical smear test samples from under 25s to be examined if a general practitioner requests an examination.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-23T16:59:11.943Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cervical Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he has had with members of the UK national screening committee on amending NHS guidelines to allow cervical smear test samples from under 25s to be examined if a GP requests an examination.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4408", "label" : {"_value" : "Biography information for Christian Matheson"} } , "tablingMemberConstituency" : {"_value" : "City of Chester"} , "tablingMemberPrinted" : [{"_value" : "Christian Matheson"} ], "uin" : "1906"} , {"_about" : "http://data.parliament.uk/resources/1150662", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150662/answer", "answerText" : {"_value" : "
No one should have to face long waits for an autism assessment. We expect services to adhere to the National Institute for Health and Care Excellence (NICE) quality standard which recommends that the length of time between referral and a first appointment to start an assessment should be no more than three months.<\/p>
<\/p>
We are determined to drive up performance nationally. We will use data on autism diagnosis waiting times, available for the first time later this year, to hold local areas to account where waiting times exceed the NICE standard.<\/p>
<\/p>
Whilst a diagnosis of autism should happen as soon as possible, it is important to recognise that formulating a diagnosis is often complex and can involve different professionals and agencies.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2019-10-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-23T12:03:57.657Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Autism: Diagnosis"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce waiting times for (a) referral to a specialist for autism diagnosis and (b) an initial assessment for autism and autism spectrum disorders.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4616", "label" : {"_value" : "Biography information for Rosie Duffield"} } , "tablingMemberConstituency" : {"_value" : "Canterbury"} , "tablingMemberPrinted" : [{"_value" : "Rosie Duffield"} ], "uin" : "1936"} , {"_about" : "http://data.parliament.uk/resources/1150683", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150683/answer", "answerText" : {"_value" : "
Cannabis-based products for medicinal use were rescheduled on 1 November 2018 to allow clinicians on the General Medical Council\u2019s \u2018Specialist Register\u2019 to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interest of patients.<\/p>
NHS England and NHS Improvement is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England\u2019s and NHS Improvement\u2019s Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-23T16:56:26.207Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many prescriptions for medical cannabis have been issued on the NHS since the rescheduling of cannabis-based products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"} } , "tablingMemberConstituency" : {"_value" : "Inverclyde"} , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"} ], "uin" : "1918"} , {"_about" : "http://data.parliament.uk/resources/1150684", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1150684/answer", "answerText" : {"_value" : "
NHS England and Improvement is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England\u2019s and NHS Improvement\u2019s Controlled Drug Accountable Officers are also collecting local intelligence in both the NHS and independent sector.<\/p>
The NHS Business Services Authority is only able to provide information on prescriptions for cannabis-based medicines that have been prescribed and submitted to the NHS Business Services Authority. It does not hold information on prescriptions for cannabis-based medicines which have been issued but not fulfilled.<\/p>
The following table shows the number of items for Nabilone and Sativex (licensed cannabis-based medicines) and unlicensed cannabis-based medicines that were prescribed on an National Health Service prescription, dispensed in the community and submitted to the NHS Business Services Authority for reimbursement between November 2017 and November 2018.<\/p>